Cargando…
Targeted 5-HT(1F) Therapies for Migraine
Migraine is a common neurological disease characterised by the presence of attacks of unilateral, severe head pain accompanied by other symptoms. Although it has been classified as the sixth most disabling disorder, the available therapeutic options to treat this condition have not progressed accord...
Autor principal: | Vila-Pueyo, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935644/ https://www.ncbi.nlm.nih.gov/pubmed/29488143 http://dx.doi.org/10.1007/s13311-018-0615-6 |
Ejemplares similares
-
CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
por: Capi, Matilde, et al.
Publicado: (2021) -
The Effect and Safety of 5-HT(1F) Receptor Agonist Lasmiditan on Migraine: A Systematic Review and Meta-Analysis
por: Gu, Ping, et al.
Publicado: (2021) -
Editorial: Lifestyle modifications to manage migraine
por: Woldeamanuel, Yohannes W., et al.
Publicado: (2022) -
The Role of Glial Cells in Different Phases of Migraine: Lessons from Preclinical Studies
por: Vila-Pueyo, Marta, et al.
Publicado: (2023) -
Animal models of migraine and experimental techniques used to examine trigeminal sensory processing
por: Harriott, Andrea M., et al.
Publicado: (2019)